Showing results (41-50 of 555) with videos related to

Sort By:
Pageof 56
Annals of Medicine|March 13, 2026
'The good idea': a commentary on a decade of barbed sutures in cesarean surgeryMaria Grazia Centurioni, Fabio Barra, Francesca Olcese, et al.
Expert Opinion on Drug Safety|April 9, 2013
Drug safety evaluation of desogestrelCarolina Scala, Umberto Leone Roberti Maggiore, Valentino Remorgida, et al.
Archives of Gynecology and Obstetrics|January 6, 2022
Concerns on ranibizumab and zoledronic acid safety for experimentally treating women with endometriosisFabio Barra, Lorenzo Ferro Desideri, Claudio Gustavino, et al.
The Lancet. Gastroenterology & Hepatology|July 3, 2026
Bowel endometriosis: from pathogenesis to clinical managementFabio Barra, Edoardo Giovanni Giannini, Maria Grazia Centurioni, et al.
Expert Opinion on Investigational Drugs|April 15, 2024
Experimental and new investigational drugs for the treatment of uterine fibroidsGiulio Evangelisti, Simone Ferrero, Umberto Perrone, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 15, 2022
Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroidsGiulio Evangelisti, Fabio Barra, Umberto Perrone, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|July 19, 2021
Quality of life and sexuality of postmenopausal women with intrauterine pathologies: a recommended three-step multidisciplinary approach focusing on the role of hysteroscopySalvatore Giovanni Vitale, Salvatore Caruso, Jose Carugno, et al.
Expert Opinion on Investigational Drugs|December 24, 2025
Targeting inflammation in endometriosis: emerging therapeutic optionsUmberto Perrone, Fabio Barra, Marco Anatrà, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|April 17, 2024
Impact of surgery for endometriosis on the outcomes of in vitro fertilizationSimone Ferrero, Irene Gazzo, Marco Crosa, et al.
Expert Opinion on Drug Safety|December 24, 2024
Safety and efficacy of pharmacotherapies for pelvic inflammatory disease and endometriosisSimone Ferrero, Umberto Leone Roberti Maggiore, Michele Paudice, et al.
Pageof 56